Literature DB >> 26961223

Changing trends in the management of well-differentiated thyroid carcinoma in Korea.

Yong Sang Lee1, Hang-Seok Chang, Cheong Soo Park.   

Abstract

A questionnaire administered in 2009 found that members of the Korean Association of Thyroid-Endocrine Surgeons (KATES) favored more aggressive treatment of well-differentiated thyroid carcinoma (WDTC) than physicians from other countries. This study assessed the changes in practical management of WDTC in Korea from the previous survey. Questionnaires were sent by e-mail to KATES members. A total of 101 members completed the questionnaire. Their responses were compared with response for the 2009 survey. Of the respondents, 53.5% and 80.2% indicated that they would perform fine-needle aspiration cytology on nodules that were <0.5 cm and 0.5-1.0 cm in diameter, respectively. If the cytology was positive, a large number of respondents favored surgical treatment, regardless of tumor size. Compared with the 2009 survey, a slightly higher percentage favored observation for patients with tumors that were <0.5 cm in diameter, and a larger percentage recommended less-than-total thyroidectomy for patients with T1 cancers. Respondents in 2014 favored aggressive lymph node dissection less, irrespective of tumor size, preferring short-term treatment with thyroid stimulating hormone suppressors. The percentage preferring postoperative high-dose radioactive iodine therapy slightly increased, whereas the percentage favoring external irradiation decreased, in 2014 compared with 2009. The management of Korean patients with WDTC changed from 2009 to 2014. In 2009, Korean respondents favored more aggressive treatment of WDTC compared with respondents from other countries. In 2014, however, Korean respondents favored a more conservative approach, especially in patients with microcarcinomas.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26961223     DOI: 10.1507/endocrj.EJ15-0635

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

1.  Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea?

Authors:  Chang-Mo Oh; Jiwon Lim; Yuh Seog Jung; Yeol Kim; Kyu-Won Jung; Seri Hong; Young-Joo Won
Journal:  Cancer Med       Date:  2021-05-12       Impact factor: 4.452

2.  Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer.

Authors:  Pablo Florenzano; Francisco J Guarda; Rodrigo Jaimovich; Nicolás Droppelmann; Hernán González; José M Domínguez
Journal:  Int J Endocrinol       Date:  2016-10-27       Impact factor: 3.257

Review 3.  Pro-Arrhythmic Signaling of Thyroid Hormones and Its Relevance in Subclinical Hyperthyroidism.

Authors:  Narcis Tribulova; Lin Hai Kurahara; Peter Hlivak; Katsuya Hirano; Barbara Szeiffova Bacova
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

4.  A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol.

Authors:  Eun Kyung Lee; Yea Eun Kang; Young Joo Park; Bon Seok Koo; Ki-Wook Chung; Eu Jeong Ku; Ho-Ryun Won; Won Sang Yoo; Eonju Jeon; Se Hyun Paek; Yong Sang Lee; Dong Mee Lim; Yong Joon Suh; Ha Kyoung Park; Hyo-Jeong Kim; Bo Hyun Kim; Mijin Kim; Sun Wook Kim; Ka Hee Yi; Sue K Park; Eun-Jae Jung; June Young Choi; Ja Seong Bae; Joon Hwa Hong; Kee-Hyun Nam; Young Ki Lee; Hyeong Won Yu; Sujeong Go; Young Mi Kang
Journal:  Endocrinol Metab (Seoul)       Date:  2021-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.